•Neurocrine Biosciences presented the first expert consensus recommendations focused on screening, diagnosis, and treatment of tardive dyskinesia in long-term care settings.
•A new analysis of KINECT-PRO data demonstrated meaningful improvements in patients aged 65 and older using INGREZZA (valbenazine) capsules.
•The recommendations were developed through a multidisciplinary Delphi panel to address gaps in managing the disease among older populations.
•The American Federation of Teachers (AFT), representing 1.8 million members, is calling for a boycott of Target in favor of local stores.
•The boycott call stems from what the union describes as an inadequate response by Target to a surge in federal immigration enforcement in Minneapolis.
•Target is facing this pressure while simultaneously attempting to execute a turnaround strategy and return to sales growth.
